Leucemia/Linfoma de Células T do Adulto no Interior da Bahia: Relato de Caso
Barra lateral de artigos
Conteúdo do artigo principal
Resumo
A leucemia/linfoma de células T do adulto (ATLL) é uma neoplasia de células T periféricas causada pelo HTLV-1, mais comum em regiões endêmicas como Japão, Caribe e América Latina. Este relato descreve o caso fatal de um paciente do sexo masculino no estado da Bahia, Brasil. A ATLL é uma doença agressiva com prognóstico desfavorável, diagnosticada por sorologia para HTLV-1 e análise hematológica. O tratamento inclui quimioterapia combinada e antirretrovirais, mas a resposta geralmente é insatisfatória. Este caso destaca a importância do diagnóstico precoce e de tratamentos direcionados. É essencial desenvolver protocolos de tratamento mais eficazes e estudos longitudinais para melhor compreender e manejar a doença.
Detalhes do artigo
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Referências
Chen PT, Onukogu D, Gotlieb G, Chaudhry R, Jaswani V, Josan K, et al. HTLV-1-Associated Lymphoma Presented as Massive Lymphadenopathy. J Investig Med High Impact Case Reports 2021;9:23247096211013236. https://doi.org/10.1177/23247096211013235.
Munir A, Raval M, Zuo C, Subik MK. HTLV-positive adult T-cell leukaemia/lymphoma with Epstein-Barr virus and hepatitis B coinfection. BMJ Case Rep 2019;12. https://doi.org/10.1136/bcr-2019-231086.
Eusebio-Ponce E, Anguita E, Paulino-Ramirez R, Candel FJ. HTLV-1 infection: An emerging risk. Pathogenesis, epidemiology, diagnosis and associated diseases. Rev Esp Quimioter 2019;32:485–96.
Nakahata S, Enriquez-Vera D, Jahan MI, Sugata K, Satou Y. Understanding the Immunopathology of HTLV-1-Associated Adult T-Cell Leukemia/Lymphoma: A Comprehensive Review. Biomolecules 2023;13:1543. https://doi.org/10.3390/biom13101543.
Poondru S, Joseph A, Harding JC, Sundaramoorthi H, Mehta-Shah N, Green P, et al. Adult T-Cell Leukemia-Lymphoma Presenting Concurrently with Myelopathy. Case Rep Oncol 2022;15:918–26. https://doi.org/10.1159/000525174.
Rauch DA, Conlon KC, Janakiram M, Brammer JE, Harding JC, Ye BH, et al. Rapid progression of adult T-cell leukemia/lymphoma as tumor-infiltrating Tregs after PD-1 blockade. Blood 2019;134:1406–14. https://doi.org/10.1182/blood.2019002038.
Barouqa M, Gil MR, Sekhri R, Popoola M, Ding J, Wang Y. HTLV-1 infection in acute t- lymphocytic leukemia/lymphoma. Autops Case Reports 2021;11:e2021307. https://doi.org/10.4322/acr.2021.307.
Gessain A, Cassar O. Epidemiological Aspects and World Distribution of HTLV-1 Infection. Front Microbiol 2012;3:388. https://doi.org/10.3389/fmicb.2012.00388.
Carvalho de Assis I, Rodrigues Alberti JG, Criado PR. Case Report: An Uncommon Clinical Case of Fatal Adult T-Cell Leukemia/Lymphoma Associated with HTLV-1 and Suspected due to Cutaneous Lesions and Epidemiologic Data. Am J Trop Med Hyg 2020;103:2113–5. https://doi.org/10.4269/ajtmh.20-0420.
Rosenthal R, Kaplan J, Ahmed M, Mims M, Weatherhead JE. Case Report: HTLV-1–Induced Adult T-Cell Leukemia and Tropical Spastic Paresis. Am J Trop Med Hyg 2021;105:1298–300. https://doi.org/10.4269/ajtmh.20-1656.
Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, et al. HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITY. Lancet 1986;327:1031–2. https://doi.org/10.1016/S0140-6736(86)91298-5.
Blattner W, LaGrenade L, Hanchard B, Fletcher V, Cranston B. Infective dermatitis of Jamaican children: a marker for HTLV-I infection. Lancet 1990;336:1345–7. https://doi.org/10.1016/0140-6736(90)92896-P.
Oliveira PD, Farre L, Bittencourt AL. Adult T-cell leukemia/lymphoma. Rev Assoc Med Bras 2016;62:691–700. https://doi.org/10.1590/1806-9282.62.07.691.
Gonçalves DU, Proietti FA, Ribas JGR, Araújo MG, Pinheiro SR, Guedes AC, et al. Epidemiology, Treatment, and Prevention of Human T-Cell Leukemia Virus Type 1-Associated Diseases. Clin Microbiol Rev 2010;23:577–89. https://doi.org/10.1128/CMR.00063-09.
Dourado I, Alcantara LCJ, Barreto ML, Teixeira M da G, Galvão-Castro B. HTLV-I in the General Population of Salvador, Brazil. JAIDS J Acquir Immune Defic Syndr 2003;34:527–31. https://doi.org/10.1097/00126334-200312150-00013.
Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 1977;50:481–92.
Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A 1980;77:7415–9. https://doi.org/10.1073/pnas.77.12.7415.
Philip S, Zahoor MA, Zhi H, Ho Y-K, Giam C-Z. Regulation of Human T-Lymphotropic Virus Type I Latency and Reactivation by HBZ and Rex. PLoS Pathog 2014;10:e1004040. https://doi.org/10.1371/journal.ppat.1004040.
Futsch N, Mahieux R, Dutartre H. HTLV-1, the Other Pathogenic Yet Neglected Human Retrovirus: From Transmission to Therapeutic Treatment. Viruses 2017;10:1. https://doi.org/10.3390/v10010001.
Tsukasaki K, Hermine O, Bazarbachi A, Ratner L, Ramos JC, Harrington W, et al. Definition, Prognostic Factors, Treatment, and Response Criteria of Adult T-Cell Leukemia-Lymphoma: A Proposal From an International Consensus Meeting. J Clin Oncol 2009;27:453–9. https://doi.org/10.1200/JCO.2008.18.2428.
Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T‐cell leukaemia‐lymphoma. Br J Haematol 1991;79:428–37. https://doi.org/10.1111/j.1365-2141.1991.tb08051.x.
Takasaki Y, Iwanaga M, Imaizumi Y, Tawara M, Joh T, Kohno T, et al. Long-term study of indolent adult T-cell leukemia-lymphoma. Blood 2010;115:4337–43. https://doi.org/10.1182/blood-2009-09-242347.
Tsukasaki K, Imaizumi Y, Tawara M, Fujimoto T, Fukushima T, Hata T, et al. Diversity of leukaemic cell morphology in ATL correlates with prognostic factors, aberrant immunophenotype and defective HTLV‐1 genotype. Br J Haematol 1999;105:369–75. https://doi.org/10.1111/j.1365-2141.1999.01323.x.
Tobinai K. Current management of adult T-cell leukemia/lymphoma. Oncology (Williston Park) 2009;23:1250–6.